Commandité
Therapeutic Devices Accelerate Sleep Apnea Adoption in Australia and New Zealand
The global sleep apnea devices market was valued at USD 7,981.80 million in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 7.90% during the forecast period from 2024 to 2031. This growth is fueled by increasing diagnosis rates, advancements in home-use technologies, and rising awareness about the serious health impacts of untreated sleep apnea. Australia and New...
0 Commentaires 0 Parts 195 Vue 0 Aperçu
Commandité
Commandité
Commandité